Long-Term Benefit–Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-Analysis

被引：0
|
作者：
April W. Armstrong
Ahmed M. Soliman
Keith A. Betts
Yan Wang
Yawen Gao
Vassilis Stakias
Luis Puig
机构：
[1] University of Southern California,Department of Dermatology, Keck School of Medicine
[2] AbbVie,Department of Dermatology, Hospital de la Santa Creu i Sant Pau
[3] Inc.,undefined
[4] Analysis Group,undefined
[5] Inc.,undefined
[6] AbbVie,undefined
[7] Inc.,undefined
[8] Universitat Autònoma de Barcelona,undefined
来源：
Dermatology and Therapy | 2022年 / 12卷
关键词：
Long-term benefit–risk profile; Risankizumab; Bimekizumab; Ixekizumab; Network meta-analysis; Moderate-to-severe plaque psoriasis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：167 / 184
页数：17
相关论文
共 50 条
  • [21] Long-term efficacy of ustekinumab in moderate-to-severe psoriasis
    Kimball, A. B.
    Gordon, K. B.
    Fakharzadeh, S.
    Yeilding, N.
    Szapary, P. O.
    Schenkel, B.
    Guzzo, C.
    Li, S.
    Papp, K. A.
    BRITISH JOURNAL OF DERMATOLOGY, 2012, 166 (04)
  • [22] Safety and Efficacy of Brodalumab for Moderate-to-Severe Plaque Psoriasis: A Systematic Review and Meta-Analysis
    Attia Attia
    Abdelrahman Ibrahim Abushouk
    Hussien Ahmed
    Mohamed Gadelkarim
    Ahmed Elgebaly
    Zeinab Hassan
    Mohamed M. Abdel-Daim
    Ahmed Negida
    Clinical Drug Investigation, 2017, 37 : 439 - 451
  • [23] Itch intensity in moderate-to-severe plaque psoriasis versus atopic dermatitis: A meta-analysis
    Shahwan, Kathryn T.
    Kimball, Alexa B.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : 1198 - +
  • [24] Safety and Efficacy of Brodalumab for Moderate-to-Severe Plaque Psoriasis: A Systematic Review and Meta-Analysis
    Attia, Attia
    Abushouk, Abdelrahman Ibrahim
    Ahmed, Hussien
    Gadelkarim, Mohamed
    Elgebaly, Ahmed
    Hassan, Zeinab
    Abdel-Daim, Mohamed M.
    Negida, Ahmed
    CLINICAL DRUG INVESTIGATION, 2017, 37 (05) : 439 - 451
  • [25] Bimekizumab for the treatment of moderate-to-severe plaque psoriasis: a meta-analysis of randomized clinical trials
    Wang, Yuqian
    Li, Sheng
    Bai, Juan
    Cai, Xiaoxuan
    Tang, Shunli
    Lin, Peiyi
    Sun, Qingmiao
    Qiao, Jianjun
    Fang, Hong
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2023, 14
  • [26] Comparative Efficacy and Relative Ranking of Biologics and Oral Therapies for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis
    Armstrong, April W.
    Soliman, Ahmed M.
    Betts, Keith A.
    Wang, Yan
    Gao, Yawen
    Puig, Luis
    Augustin, Matthias
    DERMATOLOGY AND THERAPY, 2021, 11 (03) : 885 - 905
  • [27] Comparative Efficacy and Relative Ranking of Biologics and Oral Therapies for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis
    April W. Armstrong
    Ahmed M. Soliman
    Keith A. Betts
    Yan Wang
    Yawen Gao
    Luis Puig
    Matthias Augustin
    Dermatology and Therapy, 2021, 11 : 885 - 905
  • [28] Comparative effectiveness of targeted immunomodulators for the treatment of moderate-to-severe plaque psoriasis: A systematic review and network meta-analysis
    Loos, Anne M.
    Liu, Shanshan
    Segel, Celia
    Ollendorf, Daniel A.
    Pearson, Steven D.
    Linder, Jeffrey A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (01) : 135 - +
  • [29] TARGETED IMMUNOMODULATORS FOR THE TREATMENT OF MODERATE-TO-SEVERE PLAQUE PSORIASIS: A NETWORK META-ANALYSIS COMPARING BINOMIAL AND MULTINOMIAL APPROACHES
    Fahim, S. M.
    Wright, A.
    Nikitin, D.
    McKenna, A.
    Agboola, F.
    VALUE IN HEALTH, 2024, 27 (06) : S279 - S279
  • [30] COMPARATIVE EFFECTIVENESS OF TARGETED IMMUNOMODULATORS FOR THE TREATMENT OF MODERATE-TO-SEVERE PLAQUE PSORIASIS: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
    Loos, A. M.
    Liu, S.
    Segel, C.
    Ollendorf, D.
    Pearson, S. D.
    Linder, J. A.
    VALUE IN HEALTH, 2017, 20 (05) : A210 - A210
12345